Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Spero Therapeutics Inc..
Spero Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Spero Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Spero Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Spero Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Spero Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Spero Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Spero Therapeutics Inc.- Key Facts
2.2 Spero Therapeutics Inc.- Geographic Locations
2.3 Spero Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Spero Therapeutics Inc.- Business Divisions
2.5 Spero Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Spero Therapeutics Inc. Strategic Analysis Review
3.1 Spero Therapeutics Inc.- Key Strategies
3.2 Spero Therapeutics Inc.- Company Outlook Statement
3.3 Spero Therapeutics Inc.- SWOT Analysis
3.3.1 Spero Therapeutics Inc.- Key Strengths
3.3.2 Spero Therapeutics Inc.- Key Weaknesses
3.3.3 Spero Therapeutics Inc.- Potential Opportunities
3.3.4 Spero Therapeutics Inc.- Potential Threats
3.4 Spero Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Spero Therapeutics Inc.- Business Overview
4.2 Spero Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Spero Therapeutics Inc.- Key Products
5.2 Spero Therapeutics Inc.- Key Service Areas
5.3 Spero Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Spero Therapeutics Inc.- Company History
6.2 Spero Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Spero Therapeutics Inc.- Income Statements
7.2 Spero Therapeutics Inc.- Balance Sheet
7.3 Spero Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Spero Therapeutics Inc.- Direct Competitors
8.2 Spero Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Spero Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Spero Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!